EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Small‐Molecule DEPTAC Rescues Cognitive Deficits by Targeted Dephosphorylation of Pathological Tau

Fei Sun iD, Yang Liu, Qiuzhi Zhou iD, Qingyuan Hu, Weixia Wang, Yue Xiao, Jingfen Su, Guanting Liu, Miaomiao Sun, Lixia Chen iD, Hua Li iD, Ying Yang iD und 1 weitere

Advanced Science · 2026-11 · 13 (61)

DOI: 10.1002/advs.77088 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 11.08.2026. Verfasst von Fei Sun und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, School of Basic Medicine, Key Laboratory of Education Ministry of China/Hubei Province for Neurological Disorders, Ton…. Hauptthemen laut MEDLINE: tau Proteins, Tauopathies, Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Key R&D Program of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accumulation of hyperphosphorylated Tau (p‐Tau) is a central driver of neurodegeneration in Alzheimer's disease (AD). Addressing the limitations of current therapeutics, we developed TP2, a small‐molecule DEPhosphorylation‐TArgeting Chimera (DEPTAC). TP2 is engineered to physically tether endogenous PP2A to Tau, facilitating targeted dephosphorylation. Mechanistically, TP2 induces ternary complex formation and potently reduces p‐Tau in neurons. Systemic administration of TP2 in distinct tauopathy mouse models (P301L and AAV‐hTau‐N368) significantly lowered brain p‐Tau levels, oligomers, and neurofibrillary tangles without altering global PP2A activity. Crucially, by rebalancing the phosphorylation of Tau, TP2 restored Tau's physiological function, as evidenced by the preservation of neuronal morphology, synaptic integrity, and microtubule stability. TP2 also ameliorated the dysregulated neuroimmune microenvironment. Consequently, TP2 treatment robustly reversed cognitive deficits in multiple behavioral paradigms. These findings establish TP2 as a promising therapeutic candidate that targets upstream pathological phosphorylation to halt neurodegeneration and restore cognitive function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

tau ProteinsTauopathiesAlzheimer DiseaseCognitive DysfunctionAnimalsPhosphorylationMiceDisease Models, AnimalHumansNeuronsProtein Phosphatase 2Mice, Transgenic

Stichwörter der Autor:innen

Alzheimer's diseaseDEPTACPP2ATP2Tautargeted dephosphorylation

Substanzen

tau ProteinsProtein Phosphatase 2

Autor:innen und Institutionen

  • Department of Pathophysiology, School of Basic Medicine, Key Laboratory of Education Ministry of China/Hubei Province for Neurological Disorders, Tongji Medical College, Huazhong University of Science and Technology, Wu…
  • Institute For Translational Neuroscience, Nantong First People's Hospital, Southeast University, Nantong, Jiangsu, China.
  • Institute of Structural Pharmacology & TCM Chemical Biology, Fujian Key Laboratory of Chinese Materia Medica, College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
  • Wuya College of Innovation, School of Pharmacy, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, China.
  • Department of Rehabilitation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Clinical Medicine, School of Medicine, Nanchang University, Nanchang, China.

ORCID-Profile: Fei Sun, Qiuzhi Zhou, Lixia Chen, Hua Li, Ying Yang

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • Key R&D Program of Henan Province

Zitieren

APA

Sun, F., Liu, Y., Zhou, Q., Hu, Q., Wang, W., Xiao, Y., Su, J., Liu, G., Sun, M., Chen, L., Li, H., Yang, Y., & Wang, J. Z. (2026). A Small‐Molecule DEPTAC Rescues Cognitive Deficits by Targeted Dephosphorylation of Pathological Tau. Advanced Science, 13(61). https://doi.org/10.1002/advs.77088

Vancouver

Sun F, Liu Y, Zhou Q, Hu Q, Wang W, Xiao Y, et al. A Small‐Molecule DEPTAC Rescues Cognitive Deficits by Targeted Dephosphorylation of Pathological Tau. Advanced Science. 2026;13(61). doi:10.1002/advs.77088

BibTeX
@article{Sun2026,
  author = {Sun, Fei and Liu, Yang and Zhou, Qiuzhi and Hu, Qingyuan and Wang, Weixia and Xiao, Yue and Su, Jingfen and Liu, Guanting and Sun, Miaomiao and Chen, Lixia and Li, Hua and Yang, Ying and Wang, Jian-Zhi},
  title = {A Small‐Molecule DEPTAC Rescues Cognitive Deficits by Targeted Dephosphorylation of Pathological Tau},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {61},
  doi = {10.1002/advs.77088}
}
Kostenlos starten →